MSB 3.19% 97.0¢ mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-385

  1. 479 Posts.
    lightbulb Created with Sketch. 247
    Surely they would know the results otherwise how could a trial be stopped for OE. Do they just take a punt on it?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.